This week in Washington: The House and Senate will be in recess the week of Feb. 17 in observation of Presidents Day....more
2/18/2020
/ Biosimilars ,
Centers for Medicare & Medicaid Services (CMS) ,
Controlled Substances ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
GAO ,
HRSA ,
Medicaid ,
Medicare ,
Medicare Advantage ,
Medicare Part D ,
Trump Administration
This week in Washington: Senate to hold hearing on home healthcare in rural America, House to hold hearing on protecting women's access to reproductive healthcare....more
On Dec. 12, 2019, the U.S. House of Representatives passed HR 3, the Elijah Cummings Lower Drug Costs Now Act, which would allow the government to negotiate drug prices, among other reforms. Prior to HR 3 being considered on...more
On Oct. 28, 2019, the U.S. House of Representatives unanimously passed two bills that, if enacted, require public disclosure of the discounts drug companies provide to pharmacy benefit managers (PBMs)....more
In keeping with U.S. House Speaker Nancy Pelosi’s schedule for pushing H.R. 3, the Lower Drug Costs Now Act, through the House of Representatives, the three committees of jurisdiction held mark-ups and passed the proposal, as...more
Congress -
House - In Recess -
Cummings and Sanders Seek Information About Possible Obstruction of a Congressional Investigation on Generic Drug Prices...more
This week in Washington: Hearings continue on the price of prescription drugs, Senate Committee on Finance to hold a hearing on Medicare physician payment reform, while the Senate HELP Committee will hold its second hearing...more
5/7/2019
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Inpatient Prospective Payment System (IPPS) ,
Medicare ,
Medicare for All ,
Medicare Part B ,
Medicare Part D ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Trump Administration
Upcoming Hearings/Markups -
Tuesday, April 30, 2019 -
House Committee on Rules: “Hearing on the Medicare for All Act of 2019,” H.R. 1384 -
The House Committee on Rules will hold a hearing on the Medicare for All Act...more
Upcoming Hearings -
Tuesday, Feb. 26, 2019 -
Senate Finance Committee: “Drug Pricing in America: A Prescription for Change, Part II” -
The second hearing in a series on drug pricing in the Senate Finance Committee...more
2/26/2019
/ Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
HELP ,
Medicare Advantage ,
Medicare Part D ,
OMB ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Rules ,
Vaccinations
Upcoming Hearings -
Tuesday, Feb. 26, 2019 -
Senate Finance Committee: “TBA Hearing on Drug Pricing” -
The second hearing in a series on drug pricing in the Senate Finance Committee will include the testimonies of...more
2/19/2019
/ Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Health Care Providers ,
Medicare ,
Medicare Part D ,
OMB ,
Opioid ,
Pharmaceutical Industry ,
Prescription Drugs ,
Trump Administration
Coming Week’s Highlights: State of the Union scheduled for Feb. 5; House committees continue discussion on pre-existing conditions....more
2/5/2019
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Budget Office ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
GAO ,
Medicare ,
Medicare Advantage ,
Medicare Part D ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Section 340B
This Week: The government shutdown continues; Congress finishes organizing and finalizing committee members and begins to focus on the issues. Concern has been raised that the Centers for Medicare and Medicaid Innovation...more